Pliant Therapeutics
IPOPliant Therapeutics is a biotech company in South San Francisco, United States, founded in 2016. It has raised $207.0M across 3 rounds, most recently a $100.0M Series C in February 2020.
Staking Our Claim in Integrin-Based Therapeutics
- Headquarters
- South San Francisco, California
- Employees
- 11–50
- Founded
- 2016
- Business Model
- B2B
- Website
- pliantrx.com
- Total Funding
- $207.0M
- Last Round
- $100.0M Series CFeb 2020
- Rounds
- 3
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 3 investors for this company. The full record is or through the API.
About
Pliant Therapeutics is a clinical-stage biopharmaceutical company and leader in the development of integrin-based therapeutics. The company is focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases, diving deep to understand and apply the role of integrins in disease. By targeting the molecular drivers of fibrotic diseases, Pliant seeks to unlock potentially safer and more effective therapies for patients. The company's pipeline includes programs targeting a range of fibrotic conditions, with integrin inhibitors designed for tissue-specific activity. Pliant is led by world-renowned researchers and highly experienced drug developers and is committed to sustainable ESG practices. Its office and laboratory are located at 331 Oyster Point Blvd, South San Francisco, CA.
Summary
It lists 11–50 employees. It has raised $207.0M in total across 3 rounds, most recently a $100.0M Series C round in Feb 2020. Investors include Novartis Venture Fund, Menlo Ventures and Third Rock Ventures.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Sep 2020
Sign up to see all 4 events
Funding: Series A through Series C. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/pliant-therapeutics"><img src="https://indexed.vc/api/badge/company/pliant-therapeutics" alt="Pliant Therapeutics on Indexed.vc" width="260" height="76" /></a>